Blue Bell Private Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35K | Hold |
21
| – | – | ﹤0.01% | 657 |
|
|
2025
Q1 | $1.33K | Hold |
21
| – | – | ﹤0.01% | 648 |
|
|
2024
Q4 | $1.4K | Hold |
21
| – | – | ﹤0.01% | 609 |
|
|
2024
Q3 | $1.47K | Hold |
21
| – | – | ﹤0.01% | 627 |
|
|
2024
Q2 | $1.36K | Hold |
21
| – | – | ﹤0.01% | 655 |
|
|
2024
Q1 | $1.36K | Hold |
21
| – | – | ﹤0.01% | 661 |
|
|
2023
Q4 | $1.38K | Hold |
21
| – | – | ﹤0.01% | 650 |
|
|
2023
Q3 | $1.2K | Hold |
21
| – | – | ﹤0.01% | 613 |
|
|
2023
Q2 | $1.29K | Hold |
21
| – | – | ﹤0.01% | 621 |
|
|
2023
Q1 | $1.32K | Hold |
21
| – | – | ﹤0.01% | 589 |
|
|
2022
Q4 | $1.33K | Sell |
21
-25
| -54% | -$1.59K | ﹤0.01% | 606 |
|
|
2022
Q3 | $3K | Hold |
46
| – | – | ﹤0.01% | 552 |
|
|
2022
Q2 | $3K | Hold |
46
| – | – | ﹤0.01% | 594 |
|
|
2022
Q1 | $3K | Hold |
46
| – | – | ﹤0.01% | 629 |
|
|
2021
Q4 | $3K | Buy |
+46
| New | +$3K | ﹤0.01% | 620 |
|